We studied the influence of cyclosporin-A (Cy-A) on resistance of mice to systemic infection with Candida albicans. Cy-A clearly inhibited resistance to C.
Introduction
Cell-mediated immunity is a crucial factor in host defence against systemic infection with many fungi, including Candida albicans (Baccarini et al., 1983a) . The results of several experimental studies indicate that phagocytic cells, acting through nonspecific mechanisms, are important in resistance to systemic C. albicans infection and are capable of phagocytosing and killing C. albicans in vitro (Lehrer, 1972; Sasada and Johnston, 1980; Bistoni et al., 1982 Bistoni et al., , 1986 Baccarini et al., 1983b) . In particular, previous observations suggest an important role for polymorphonuclear leucocytes (PMNL) and macrophages in resistance to C. albicans infections in vivo (Lehrer, 1969; Ruthe et al., 1978; Hurtrel et al., 1980; Baccarini et al., 1985) . The killing activity in vitro is not affected by treatment with anti-Thy 1 serum or anti-asialo GM-1 serum plus complement (Baccarini et al., 1983a) and phagocytic cells isolated from nude mice are also actively candidacidal (Baccarini et al., 19833) .
Immunomodulating agents have been employed previously to evaluate the possible role of different components of the immune system in experimental infections, In the case of experimental C. albicans route in a volume of 0.1 m1/10 g of body weight. Control mice received Miglyol 8 12 alone. Cyclophosphamide (CY, Endoxan; Asta Werke, FRG) was dissolved in sterile NaClO.85% immediately before use and injected i.p. at a dose of 150 mg/kg in a volume of 0.1 m1/10 g of body weight.
Candida albicans
C. albicans, laboratory strain CA-6, was isolated from a clinical specimen (Marconi et al., 1976) . It was grown at 28°C with mild agitation in low-glucose Winge medium (Mattia et al., 1982) containing glucose 0.2% w/v and yeast extract (BBL Microbiology Systems, Cockeysville, MD, USA) 0.3% w/v until the stationary phase of growth was reached at about 24 h. Under these conditions, cultures yielded c. 3 x lo8 cells/ml, and the organism grew as an essentially pure yeast-phase population. Cells were harvested from the 24-h culture by low-speed centrifugation (600g), washed twice in saline and diluted to the desired density.
Leucocyte counts
Mice were bled from the retro-orbital sinus (10 mice were used for each determination). Cell counts were made by diluting anticoagulated blood 1 in 20 in Turk solution and counting the cells in a counting chamber. Differential cell counts were made on blood smears stained by the May-Griinwald-Giemsa method by counting 200 leucocytes on each slide. Standard errors never exceeded 10% of the mean and, therefore, have been omitted from the results.
Preparation ofphagocytic cells
Peritoneal PMNL were obtained from the peritoneal cavities of mice 18 h after i.p. injection of 1 ml of thioglycolate broth 10%. Cells were harvested by peritoneal washing and approximately 85% of them were identified as PMNL on morphological criteria. When specified, experiments were performed with circulating PMNL separated from peripheral blood by FicollHypaque solution as described by Klock and Bainton (1 976) .
Spleen cells were harvested by adherence to plastic. Resident or thioglycolate-induced (i.p. injection of broth 4 days earlier) peritoneal cells were harvested as above and suspended (1 x lo7 cells) in 10 ml of RPMI 1640 medium (Eurobio Laboratories, Paris) in 93-mm plastic petri dishes (Nunc InterMed, Roskilde, Denmark). After incubation for 2 h at 37°C in an atmosphere of C 0 2 5% in air, the dishes were washed thoroughly with RPMI 1640 medium to remove the non-adherent cells. The adherent cells were recovered by scraping the dish with a "rubber policeman", and were washed and suspended in RPMI 1640 medium supplemented with fetal calf serum (GIBCO Laboratories, Grand Island, NY, USA) lo%, 25 mM HEPES (N-2-hydroxyetyl-piperazine-N'-2-ethanesulphonic acid) buffer (Eurobio), and gentamicin sulphate 0.1% (hereafter referred to as complete RPMI 1640 medium). More than 99% of the recovered cells had the morphology of macrophages in Giemsa-stained smears and their viability was 85-90%.
Adoptive transfer of lymphocytes
The non-adherent cells separated by the plastic adherence fractionation method (see above) were passed over a nylon fibre column as described by Julius et al. (1973) . The fraction that was recovered comprised 98-99% T-lymphocytes, as determined by their morphology in May-Griinwald-Giemsa stained smears and confirmed by immunofluorescence with fluorescein-labelled antiThy 1, 2 antibodies (New England Nuclear). These lymphocytes were injected intravenously (i.v.) into recipient mice (25 x lo6 cells/mouse).
Interferon
Cloned murine gamma-interferon (IFN-y) was kindly provided by Genentech, Inc. (South San Francisco, CA, USA).
Transfer of PMNL and C . albicans mixtures C. albicans cells (1 x lo4) were mixed with 20x lo4 PMNL from normal or Cy-A-treated mice and incubated at 37°C in air + C 0 2 5%. After contact for 1 h, the 0.5-ml volumes of the mixtures were injected i.v. into CYimmunodepressed mice.
Measurement of phagocytic activity in vitro
Microscopic examination of phagocytic cell function was performed by mixing equal volumes (0.1 ml) of effector cells, the indicator dye methylene blue, and a suspension of heat-inactivated yeast cells in sterile polypropylene tubes (Becton Dickinson) at an effector cell: yeast cell ratio of 1 : 10. Triplicate samples of the mixtures were incubated for different times at 37°C. Phagocytic cells were separated from non-phagocytosed C. albicans by centrifugation on a fetal bovine serum gradient (Shalaby et al., 1985) and 0-1-ml samples of the harvested phagocytic cells were used to prepare wet mounts for microscopy. The phagocytic activity of effector cells was expressed according to the following formula : percentage phagocytic activity = number of cells containing one or more yeast cells/lOO cells counted.
In vitro cytotoxicity assays 5 1 Cr release assay. The candidacidal activity of various effector cell populations was assessed by the technique described by Bistoni et al. (1982) . Briefly, PMNL or single-cell suspensions from the spleen were prepared and different numbers of effector cells in 0.1 ml of the suspension were mixed in U-shaped 96-well microtitra-tion plates with 0.1 ml of a suspension of 5 x lo4 'lCrlabelled yeast cells (2x lo8 cells were incubated with 300 pCi of Naz5'Cr04 for 2 h). After incubation for 4 h at 37°C in air + COz 5%, the plates were centrifuged at 800 g for 10 min, and the radioactivity in 0.1 ml of the supernate was measured in a y-scintillation counter ( -(cpm experimental groupj x 100 -cpm spontaneous group) x 2 1 total cpm in which total cpm is the radioactivity incorporated by 5 x lo4 candida cells.
Inhibition assay by plate counts. Phagocytic cells (5 x lo5 in 0.1 ml of suspension per well) were mixed in Ushaped 96-well microtitration plates (Greiner Labortechnick, Nurtingen) with C. albicans cells (5 x lo4 cells in 0.1 ml of suspension/well). After incubation for 4 h at 37°C in air + C 0 2 5%, the plates were shaken vigorously, and serial dilutions in distilled water were made from each well. Cell suspensions were incubated with distilled water until microscopic examination revealed the complete disruption of phagocytes. Triplicate samples from each dilution were spread on Sabouraud glucose agar. The numbers of cfu were counted after incubation for 18 h at 37°C. Control cultures were C. albicans cells incubated without phagocytes.
Culture of C. albicans from kidneys
Both kidneys of normal or Cy-A treated mice, challenged i.v. with 5 x lo5 C. albicanscells, were removed aseptically and placed together in a tissue homogeniser with 3ml of sterile NaCl 0.85%. The number of C. albicans cfu in a specimen was determined by a plate dilution method with culture on Sabouraud glucose agar. The colonies were counted after incubation at 37°C for 48 h, and the results were expressed as the number of cfu/ organ.
Statistical analysis
Differences in survival times were assessed by the Mann-Whitney U test. Differences in the numbers of cfu or the amounts of the specific radiolabel release in the invitro microcytotoxicity assays were assessed by Student's t test. Each experiment was repeated three to five times.
Results
Efect of Cy-A treatment on the resistance of mice to systemic challenge with C. albicans
We performed experiments to test the influence of Cy-A treatment on the resistance of mice to i.v.
injection of a lethal dose (5 x lo5 cells) of C. albicans ( fig. 1) . Treatment, at different times before challenge and with different doses of Cy-A, caused a significant reduction of median survival time (MST) in some of the groups compared with untreated controls. In particular, doses of 50,25, or 12.5 mg/kg, given 1 day before C. albicans challenge, or 50 or 25mg/kg, given 3 days before, reduced the MST. By contrast, none of the four doses of Cy-A given 7 days before challenge significantly reduced MST when compared with untreated controls. These data indicate that Cy-A induces a rapid and transient depression of the mechanisms responsible for resistance to C. albicans challenge in vivo.
We further examined the effect of Cy-A treatment before challenging with different doses of C. albicans (table I) . The administration of Cy-A 25 mg/kg, 1 or 3 days before challenge, significantly impaired host resistance to systemic infection following challenge with different doses of C. albicans. This suppressive effect was most evident when mice challenged with 5 x lo4 C. albicans cells had been pretreated with Cy-A 1 or 3 days before challenge. In this case the MST was 17 days, while the control mice survived indefinitely (> 60 days).
Efect of Cy-A treatment on recovery of C. albicans from the kidneys of mice after i.v. challenge
We have shown previously that the number of C. albicans cfu recovered from the kidneys correlates well with the level of resistance of mice to challenge with C. albicans (Bistoni et al., 1984) . To examine further the nature of Cy-A-induced depression of resistance to C. albicans infection in vivo, we also compared the recovery of C . albicans cfu from the kidneys of untreated animals with those from Cy-A-treated animals (table 11). The counts of cfu from the kidneys of animals treated with Cy-A 1 or 3 days before C. albicans challenge were compared with those of untreated animals. Cy-A pretreatment caused a significant increase in the number of cfu that was evident after 24 h and was more marked 48 h after challenge. As expected, Cy-A treatment caused a significant reduction in host resistance as shown by the comparison of MST of the different groups of treated and untreated animals.
A. VECCHIARELLI ET AL. ., untreated controls; 0 , mice (10 mice/group) treated with Cy-A l(A), 3(B) or 7(C) days before challenge. Vertical bars represent the survival ranges (days); *p < 0.01 (Cy-A treated mice versus untreated).
Eflect of Cy-A treatment on PMNL-mediated cytotoxic activity against C. albicans
We performed experiments to determine the number and candidacidal activity of PMNL in mice treated with Cy-A (table 111). Treatment with Cy-A (25 mg/kg, i.p.), by any administration schedule, did not significantly alter the number of peripheral lymphocytes nor the number of monocytes and PMNL. Therefore, we examined peripheral and thioglycolate-induced PMNL for their cytotoxicity against 'Cr-labelled C. albicans in vitro as well as for their ability to inhibit C. albicans growth in a cfu assay, as previously described (Bistoni et al., 1982) . A significant reduction of cytotoxic activity and reduction of inhibition of C. albicans cfu recovery by peripheral and thioglycolate-induced PMNL was evident in the groups of animals treated 1 or 3 days before with Cy-A 25 mg/ kg. We also evaluated the phagocytic activity of PMNL from Cy-A treated mice. As shown in fig.  2 , PMNL from animals treated with Cy-A 3 days before the PMNL were harvested showed significantly reduced phagocytic activity. Our data suggest that Cy-A treatment did not alter the number of circulating PMNL but significantly reduced their ability to phagocytose and inhibit the growth of C.
albicans.
On the basis of these observations, we investigated the possibility that the candidacidal activity of resident, thioglycolate-induced macrophages and splenic macrophages could be affected also. The results are shown in table IV. The candidacidal activity of these different macrophage populations was not affected by Cy-A treatment, suggesting that the reduction of resistance to C. albicans challenge in vivo after Cy-A treatment was due to the effects on candidacidal activity of PMNL but not of macrophages.
Protective ability of PMNL from Cy-A-treated mice in transfer experiments
We reported previously that it is possible to increase significantly the MST of immunodepressed mice infected with C. albicans by adoptive transfer of PMNL (Baccarini et al., 1985) . To document further the effect of treatment with Cy-A on PMNL activity, we performed transfer experiments with PMNL from untreated or Cy-A-treated animals (table V). The i.v. injection of PMNL from untreated donors into CY-treated recipients significantly increased the MST of animals challenged with C . albicans (group 2) compared with control animals (group 1). In contrast, the adoptive transfer of PMNL from Cy-A-treated (25 mg/kg 3 and 1 day before the assay) donors did not result in any significant protection against C . albicans challenge (groups 3 and 4). These results demonstrate that PMNL of Cy-A-treated animals, unlike PMNL from normal donors, are not able to protect immunodepressed mice.
Efect of diferent routes of Cy-A administration on PMNL activity
We also tested the possible effect of Cy-A administration by different routes. Cy-A doses were injected i.p., S.C. or i.m. and we evaluated both resistance to C . albicans challenge in vivo and cytotoxic activity of PMNL in vitro. As shown in table VI, the i.p. or i.m. injection of Cy-A significantly decreased the resistance to C . albicans challenge in vivo as well as the candidacidal activity of PMNL in vitro. However, S.C. administration failed to cause any significant effect. These results further indicate the relevance of Cy-A inhibition of PMNL activity as a possible mechanism responsible for the depression of resistance in vivo.
Partial reconstitution of PMNL activity in Cy-Atreated animals by transfer of T lymphocytes
Cy-A selectively inhibits T-cell functions (Borel et al., 1976; Larsson, 1980; Wiesinger and Borel, 1980; Bunjes et al., 1981; Britton and Palacios, 1982; Kauffman et al., 1984) . To study further the effect of Cy-A on PMNL activity, we examined the possible effect of T-cell transfer on PMNL activity in Cy-A-treated mice. Animals were treated with Cy-A 50mg/kg 3 days before the assay; 2 days before the assay, one group of mice was given 2.5 x lo7 cells of a T-lymphocyte enriched population from normal donors (see Material and methods) by i.v. injection. Both the 'lcr-release assay and the cfu-inhibition assay indicated that lymphocyte transfer partly reconstituted the PMNL activity (table VII). These data suggest that the Cy-Ainduced decline of PMNL activity could be due, at least in part, to the effect of Cy-A on T lymphocytes. 1986). To examine further the possible mechanism of Cy-A-induced inhibition of PMNL activity, we measured the effect of IFN-y on the activity, in vitro, of PMNL from Cy-A-treated and normal control mice ( fig. 3 ). The incubation of PMNL with different doses of IFN-y resulted in a significant augmentation of their activity as evaluated by both "Cr-release and cfu-inhibition assay. This potentiating effect was more marked for PMNL from Cy-A-treated animals than for those from normal animals. These data could indicate that lack of IFN-y production in Cy-A-treated mice may ac- count, at least in part, for the decrease of PMNL candidacidal activity.
Partial reconstitution of PMNL activity in

Discussion
We have shown that phagocytic cells play an important role in resistance to experimental C. albicans infection in vivo (Baccarini et al., 1983a; Bistoni et al., 1986) . We also found that modulation of numbers of macrophages and PMNL or their activity, or both, may influence this resistance, suggesting that the phagocytic killing mediated by macrophages and PMNL could play a role. Previous observations indicate that macrophages and PMNL are able to kill C . albicans in vitro as well as inhibit colony formation (Lehrer, 1972) . Our observations tend to exclude a direct role for T cells and natural killer (NK) cells in host resistance against infection as well as in killing or growth inhibition, or both, of C. albicans in vitro. Furthermore, anticandida effector cells lack typical markers of either T or NK cells and their in vivo reactivity shows characteristics which differ from those of NK activity, including age and genetic influences (Baccarini et al., 1983b) .
To analyse further the mechanisms that may be involved in resistance to C. albicans infection, we manipulated host reactivity by treating animals with Cy-A. Unlike other agents, Cy-A does not attack all lymphocyte populations indiscriminately, but acts only against selected ones. It has been reported that Cy-A selectively depletes T cells, and, in particular, T-helper and T-cytotoxic cells. More specifically, it acts at an early stage in the life cycle of T lymphocytes, inhibiting their activation by blocking the intercellular message carried by interleukin-2 (11-2) (Bunjes et al., 1981 ; Kaufmann et al., 1984; Hess and Colombani, 1986) . It has been proposed that Cy-A spares both myeloid tissue and the non-specific arm of the defence system and that it has no effect on neutrophils or macrophages (Weinbaum et al., 1984; Lun et al., 1985) . Although additional actions may yet be defined, the major effect of Cy-A seems to be its ability to inhibit Tcell functions by acting at three distinct but related stages in the process of T-cell activation: (1) inhibiting T cell help of accessory cells for the synthesis of IL-1; (2) preventing IL-2-producing T cells from expressing receptors for IL-1 and suppressing the synthesis of IL-2; (3) rendering T cells unresponsive to IL-2 (Bore1 et al., 1976; Bunjes et al., 198 1 ; Hess and Colombani, 1986) .
The data reported here indicate that Cy-A decreases the spontaneous reactivity of PMNL against C. albicans as evaluated by in-vivo and invitro experiments. Evidence for this depressive effect on PMNL was a significantly decreased cytotoxic activity in vitro, as shown by the cfu assay and by a 4-h ' Cr-release assay against radiolabelled C. albicans. Furthermore, PMNL from Cy-A treated mice also showed significantly decreased phagocytic activity in vitro ( fig. 2 ) which could account for the decreased cytotoxic activity observed (table 111) . This depressed activity was also evident in vivo. Cy-A decreased resistance to C. albicans challenge ( fig. 1 ; tables I and VI) and also reduced significantly the protective capability of PMNL transferred from Cy-A-treated mice into immunodepresse mice to a subsequent challenge with C. albicans (table V). The decreased resistance to C. albicans challenge in vivo also indicates that Cy-A impairs the activity of PMNL in vivo. However, Cy-A did not affect the viability and candidacidal activity of PMNL when incubated in vitro for different times and with different drug concentrations (data not shown).
Because of previous observations that T lymphocytes are the cell population mainly affected by Cy-A treatment (Borel et al., 1976; Larsson, 1980; Wiesinger and Borel, 1980; Bunjes et al., 1981; Britton and Palacios, 1982 ; Kauffman et al., 1984), we tested the possibility that the depressive effect on PMNL activity was a consequence of the drugmediated effect on T lymphocytes. We evaluated the effect of treatment with Cy-A (25 mg/kg 1 or 3 days before assay) on T-cell mediated alloreactivity in vivo or cytotoxic T-lymphocyte generation in vitro, as well as the proliferative response to PHA. Our results showed that the treatments that reduced PMNL candidacidal activity also inhibited these T-cell functions (data not shown). These observations suggested a possible relationship between the effects of Cy-A on T-cell activity and the effects on PMNL candidacidal activity. Therefore, we performed transfer experiments in an attempt to reconstitute PMNL activity in Cy-Atreated mice. Our results (table VII) show clearly that transfer of nylon non-adherent, T-cell enriched, spleen cells partly reconstituted the PMNL candidacidal activity in vivo.
We also examined the effect of treatment of PMNL from Cy-A-treated mice with IFN-y in vitro. Our data ( fig. 3) show that IFN-y treatment partly reconstituted the PMNL candidacidal activity. On the basis of our data and previously reported observations that Cy-A strongly affects IL-2 production by T lymphocytes and that IL-2 may, in turn, stimulate the production of IFN-y, we suggest that Cy-A-induced depression of PMNL activity could be due, at least in part, to inhibition of T-cell dependent IL-2 and IFN-y production (Farrar et aZ., 1986) . Moreover, recently IFN-y has been reported to stimulate PMNL-mediated candidacidal activity (Djeu et al., 1986) , which suggests a possible physiological role of IFN-y in maintaining levels of PMNL activity necessary for host defence against infections. These proposed mechanisms may account, in part, for the Cy-A-induced decrease of resistance to C. albicans infection, although other cells and factors may also be involved in this phenomenon.
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